Premium
In vivo activated caspase‐3 cleaves PARP‐1 in rat liver after administration of the hepatocarcinogen N ‐nitrosomorpholine (NNM) generating the 85 kDa fragment
Author(s) -
WęsierskaGądek Józefa,
Gueorguieva Marieta,
Wojciechowski Jacek,
TudzarovaTrajkovska Slavica
Publication year - 2004
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.20181
Subject(s) - poly adp ribose polymerase , caspase , apoptosis , microbiology and biotechnology , immunostaining , caspase 3 , dna fragmentation , in vivo , biology , fragmentation (computing) , chemistry , immunohistochemistry , polymerase , biochemistry , programmed cell death , dna , immunology , genetics , ecology
We reported previously that treatment of rats with the hepatocarcinogen N ‐nitrosomorpholine (NNM) caused severe hepatotoxicity associated with apoptosis of hepatocytes beginning 12 h after administration of NNM. We observed that poly(ADP‐ribose) polymerase 1 (PARP‐1), one of the major nuclear targets for caspases, was proteolytically degraded generating primarily 64 and 54 kDa fragments. Interestingly, at 20, 30, and 40 h post‐treatment a 85 kDa cleavage product of PARP‐1 resembling that generated by caspase‐3 appeared additionally in hepatocytes. More detailed analysis performed in the present study revealed that the 85 kDa fragment of PARP‐1 was generated in the liver in 10 of 17 (60%) animals examined between 20 and 40 h after NNM administration. The caspase‐3 generated 85 kDa fragment was detected solely in hepatocytes undergoing apoptosis as evidenced by immunostaining performed with the antibody recognizing exclusively PARP‐1 cleaved at position 214/215. The appearance of the 85 kDa fragment of PARP‐1 in the liver nuclei coincided temporally with an significant increase of caspase‐3 activity in hepatocytes. In contrast, in testis samples obtained from the same animals, no changes characteristic for apoptosis such as induction of caspases activity or degradation of nuclear PARP‐1 could be detected. Our results evidence unequivocally that PARP‐1 in liver is not resistant to caspases and can be processed in vivo by activated caspase‐3 producing the p85 kDa fragment. Moreover, the caspase‐3 induced PARP‐1 fragmentation coinciding with the increase of caspase‐3 activity was detected solely in the target organ and exclusively in hepatocytes undergoing apoptosis. Considering the fact that the caspase‐3 mediated PARP‐1 cleavage occurred only in 60% of animals tested between 20 and 40 h, it becomes obvious that the cellular response in vivo to the same trigger(s) strongly varies and may depend on a variety of intrinsic factors. It remains to elucidate which additional factors may be involved in the modulation of cellular response to the strong insults thereby activating different pathways and generating distinct outcomes. © 2004 Wiley‐Liss, Inc.